Hologic
Q3 2022 Earnings Call
Jul 27, 2022, 4:30 p.m. ET
Contents:
- Prepared Remarks
- Questions and Answers
- Call Participants
Prepared Remarks:
Operator
Good afternoon, and welcome to Hologic's third quarter fiscal 2022 earnings conference call. My name is Cody, and I am your operator for today's call. Today's conference is being recorded.[Operator instructions] And I would now like to introduce Ryan Simon, vice president of investor relations. Please go ahead.
Ryan Simon -- Vice President, Investor Relations
Thank you, Cody. Good afternoon, and thank you for joining Hologic's third quarter fiscal 2022 earnings call. With me today are Steve MacMillan, the company's chairman, president, and chief executive officer; and Karleen Oberton, our chief financial officer. Our third-quarter press release is available now on the Investors section of our website, along with an updated corporate presentation.
We will also post our prepared remarks to our website shortly after we deliver them and a replay of this call will be available through August 26. Before we begin, we would like to inform you that certain statements we make today will be forward-looking. These statements involve known and unknown risks and uncertainties that may cause actual results to differ materially from those expressed or implied. Such factors include those referenced in the safe harbor statement included in our earnings release and SEC filings.
Also during this call, we will discuss certain non-GAAP financial measures. A reconciliation to GAAP can be found in our earnings release. Two of these non-GAAP measures are: one, organic revenue, which we define as constant currency revenue, excluding the divested blood screening business, and revenue from acquired businesses owned by Hologic for less than one year; and two, organic revenue, excluding COVID-19, which excludes COVID-19 assay revenue, revenue related to COVID-19 and discontinued product sales in Diagnostics; finally, any percentage changes we discuss will be on a year-over-year basis and revenue growth rates will be in constant currency unless otherwise noted. Now I'd like to turn the call over to Steve MacMillan, Hologic, CEO.
Steve MacMillan -- Chairman, President, and Chief Executive Officer
Thank you, Ryan, and good afternoon, everyone. We are pleased to discuss our financial results for the third quarter of fiscal 2022. Our results continue to showcase the strength, durability, and diversity of our business. Total revenue was just over $1 billion and non-GAAP earnings per share was $0.95.